The analysis of cancer cell line sensitivity and cell cycle profiles, hill slopes of dose–response curves, PI3K and MDA activities all revealed that the cellular activity of BKM120 matches the mode of action of MTD147 and known microtubule disruptors such as nocodazole and colchicine. This evidence concerns the gene PIK3CD and cancer.